Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-214-6 | CAS number: 5328-37-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- September 18 - October 13, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- February 2015
- Deviations:
- yes
- Remarks:
- see "Any other information on Material and Methods"
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- L-arabinose
- EC Number:
- 226-214-6
- EC Name:
- L-arabinose
- Cas Number:
- 5328-37-0
- Molecular formula:
- C5H10O5
- IUPAC Name:
- L-arabinose
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No. of test material: AD16081001
- Expiration date of the batch: 2019-08-09
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature
- Stability under test conditions: Stable under ambient conditions
In vitro test system
- Details on the study design:
- Skin sensitisation (In vitro test system) - Details on study design:
Dose Selection for Experiment I and II
In accordance with the OECD guideline 442D, the maximum final test item concentration should be 2000 μM. For a test chemical which has no defined molecular weight, the final test item concentration 400 μg/mL can also be used. Alternative concentrations may be used upon justification (e.g. in case of cytotoxicity or poor solubility). Since no cytotoxic reaction was observed in the CRFT the following 12 nominal concentrations were chosen for experiment I and II:
269 μM, 323 μM, 388 μM, 465 μM, 558 μM, 670 μM, 804 μM, 965 μM, 1157 μM, 1389 μM, 1667 μM, 2000 μM
In the main experiments, a reduction of the viability below 70 % is considered as cytotoxic and is not allowed to be evaluated for luciferase induction
Experimental Performance
Experiment I and II were performed in the same way. Experiment II serves only to confirm the results of experiment I. The exposure dates were 10. Oct. 2017 and 11. Oct. 2017. At the time of seeding the cells were 80 % confluent. The cells were washed twice with PBS (without Ca2+/Mg2+) containing 0.05% EDTA. Afterwards the cells were trypsinized until the cells detached. To stop this reaction, medium no. 2 was added. After centrifugation (5 min at 380 * g), the supernatant was discarded and the cells were resuspended in medium no. 2. After quantification, the cell suspension was adjusted to 83000 (±10 %) cells/mL. 120 μL of the cell suspension were seeded in two clear flat bottom 96 well plates (one for viability and one for luciferase induction measurement). Both plates were incubated at 37 ± 1 °C and 5.0 ± 0.5 % CO2 in a humidified atmosphere for 24 h and 30 min in Experiment I and 24 h and 45 min in Experiment II. The treatment procedure was performed on both 96 well plates identically: After the incubation time the medium was removed from the cells and 150 μL medium no. 3 were added to each well. Afterwards 50 μL of each single test item concentration and the controls were added to the cells in triplicates (test item concentrations). 24 wells were used for solvent control, 12 wells were used for growth control (cells + medium no. 3), 6 wells were used for negative control, 5 wells for positive control and 1 well for blank. The plates were sealed with breathable tape to avoid evaporation of volatile compounds and to avoid cross contamination between wells. Afterwards the plates were incubated for 48 h at 37 ± 1 °C in a humidified atmosphere containing 5.0 ± 0.5 % CO2.
For the evaluation of the viability, one of the plates was used:
The MTT working solution was prepared by mixing 9 parts of medium no. 3 with 1 part of MTT solution. All solutions were removed from the wells of the 96 well plate and 200 μL MTT working solution were added to each well. The plates were incubated for 2 h at 37 ± 1 °C and 5.0 ± 0.5 % CO2 in a humidified atmosphere. Afterwards the solution was removed and 100 μL of lysis buffer were added to each well. The plate was agitated for 5 min before it was measured at 570 nm and at 690 nm (reference) at the photometer. The cell viability is measured by the reduction of the tetrazolium dye MTT (3-(4,5- Dimethyl thiazole 2-yl)-2,5-diphenyltetrazolium-bromide) (yellow color) to its insoluble formazan (purple color) in living cells and therefore indicates the amount of living cells. After the measurement of the color change, the values were transferred in a validated spreadsheet for the calculation of the viability.
For the evaluation of the Luciferase induction, the second plate was used:
For the evaluation of the Luciferase expression all solutions were removed from the wells and the cells were washed twice with 300 μL PBS (with Ca2+/Mg2+). Afterwards 100 μL per well of a Lysis buffer were added to the cells and incubated for 5 min at room temperature. During this process, the plate was slightly moved. Afterwards 100 μL Steady-Glo® Reagent were added to each well and the plate was shaken again slowly for 5 min at room temperature. Then, 160 μL per well were transferred to a white flat bottom 96 well plate and the luminescence was measured for 2 seconds using a luminometerFor calculation of the luciferase induction as well as the relative viability a validated Microsoft Excel® file was used.
Results and discussion
- Positive control results:
- All control substances indicated the expected effect. No considerable reduction of the viability was detected (all values > 84 %). Regarding the Luciferase induction, the growth control and the negative control did not exceed the threshold of 1.5 fold in comparison to the solvent control (growth control: 0.9 fold, negative control: 1.2 fold). However, the positive control induced a clear effect with an induction value of 4.5 fold in comparison to the solvent control.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: Experiment I
- Parameter:
- other: fold Luciferase induction
- Value:
- 0.9
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: Experiment II
- Parameter:
- other: fold Luciferase induction
- Value:
- 0.9
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: Yes
Any other information on results incl. tables
Table 1: Acceptability of experiment I and II
Criteria |
Found in Experiment I |
Found in Experiment II |
The average induction for the positive control should be ≥ 2.5 fold and it should have a relative viability of at least 70 %. |
Positive control Fold induction: 4.5 Relative viability: 84.7 % |
Positive control Fold induction: 5.4 Relative viability: 94.2 % |
The induction triggered by the negative control and growth control should be < 1.5 fold as compared to the induction of the solvent control and the viability should be above 70%. |
Negative control: Fold induction: 1.2 Relative viability: 104.9 % Growth control: Fold induction: 0.9 Relative viability: 141.9 % |
Negative control: Fold induction: 1.0 Relative viability: 112.0 % Growth control: Fold induction: 1.0 Relative viability: 136.5 % |
The average percentage standard deviation (luciferase induction) of the variability in at least 21 solvent control wells should be below 20 %. |
11.96 % |
11.21 % |
At least 3 test concentrations must be within viability limits, i.e. have relative viability of at least 70 %. |
12 concentrations are analysable |
12 concentrations are analysable |
Table 2: Summary of the Results of Experiment I
Parameter |
|
Induction of Luciferase |
Viability of the Cells |
||||
Concentration |
Induction |
Standard Deviation |
Standard Deviation |
Relative Viability |
Standard Deviation |
Standard Deviation |
|
[μM] |
fold |
|
[%] |
[%] |
|
[%] |
|
Solvent Control |
- |
1.0 |
0.12 |
11.96 |
100.0 |
5.69 |
5.69 |
Growth Control |
- |
0.9 |
0.07 |
7.80 |
141.9 |
6.20 |
4.37 |
Negative Control |
5000 |
1.2 |
0.08 |
6.52 |
104.9 |
5.998 |
5.69 |
Positive Control |
120 |
4.5 |
0.13 |
2.83 |
84.7 |
2.20 |
2.59 |
Test item |
269 |
1.1 |
0.07 |
6.41 |
110.1 |
1.66 |
1.51 |
323 |
1.0 |
0.08 |
8.19 |
104.9 |
3.07 |
2.92 |
|
388 |
1.0 |
0.08 |
8.46 |
100.7 |
3.18 |
3.16 |
|
465 |
1.0 |
0.04 |
4.00 |
101.3 |
2.14 |
2.11 |
|
558 |
1.0 |
0.11 |
10.67 |
103.3 |
7.22 |
6.99 |
|
670 |
1.0 |
0.03 |
3.32 |
101.4 |
6.13 |
6.05 |
|
804 |
0.9 |
0.05 |
5.77 |
105.5 |
2.48 |
2.35 |
|
965 |
1.0 |
0.05 |
5.62 |
94.0 |
1.14 |
1.21 |
|
1157 |
0.9 |
0.06 |
6.58 |
93.4 |
3.24 |
3.47 |
|
1389 |
0.9 |
0.05 |
5.86 |
98.1 |
0.65 |
0.66 |
|
1667 |
0.9 |
0.06 |
7.53 |
95.8 |
2.08 |
2.17 |
|
2000 |
0.9 |
0.06 |
6.88 |
100.2 |
1.20 |
1.20 |
Table 3: Summary of the Results of Experiment II
Parameter |
|
Induction of Luciferase |
Viability of the Cells |
||||
Concentration |
Induction |
Standard Deviation |
Standard Deviation |
Relative Viability |
Standard Deviation |
Standard Deviation |
|
[μM] |
fold |
|
[%] |
[%] |
|
[%] |
|
Solvent Control |
- |
1.0 |
0.11 |
11.21 |
100.0 |
5.89 |
5.89 |
Growth Control |
- |
1.0 |
0.08 |
8.22 |
136.5 |
4.39 |
3.22 |
Negative Control |
5000 |
1.0 |
0.04 |
4.04 |
112.0 |
4.68 |
4.18 |
Positive Control |
120 |
5.4 |
0.29 |
5.38 |
94.2 |
7.75 |
8.22 |
Test item |
269 |
1.2 |
0.09 |
7.13 |
123.0 |
4.94 |
4.02 |
323 |
1.1 |
0.05 |
4.03 |
111.3 |
3.21 |
2.88 |
|
388 |
1.1 |
0.14 |
13.12 |
106.7 |
2.57 |
2.41 |
|
465 |
1.1 |
0.09 |
8.52 |
103.8 |
2.77 |
2.67 |
|
558 |
1.1 |
0.08 |
7.77 |
102.5 |
6.36 |
6.21 |
|
670 |
1.0 |
0.02 |
2.52 |
102.3 |
4.68 |
4.58 |
|
804 |
1.0 |
0.02 |
1.68 |
107.2 |
5.00 |
4.66 |
|
965 |
1.0 |
0.06 |
6.63 |
110.7 |
3.14 |
2.84 |
|
1157 |
1.1 |
0.06 |
5.27 |
106.4 |
1.34 |
1.26 |
|
1389 |
1.0 |
0.07 |
7.02 |
102.8 |
0.88 |
0.86 |
|
1667 |
1.0 |
0.17 |
17.22 |
99.8 |
7.77 |
7.78 |
|
2000 |
0.9 |
0.03 |
3.46 |
99.9 |
2.58 |
2.58 |
Applicant's summary and conclusion
- Interpretation of results:
- other: no activation of keratinocytes
- Remarks:
- The data generated with this method may not be sufficient to conclude on the absence of skin sensitisation potential of chemicals and should be considered in the context of integrated approach such as IATA.
- Conclusions:
- In an in vitro skin sensitisation assay according to 442D, the test item did not induce luciferase activity in at least two independent experiment runs.
- Executive summary:
In an in vitro skin sensitisation assay according to 442D, the potential of the test item to activate the Nrf2 transcription factor, by using the LuSens cell line was investigated. The assay was performed in two independent experiments. 12 concentrations of the test item were evaluated. The exposure time was 48 h. The following nominal concentrations of the test item were investigated in experiment I and II:
269 μM, 323 μM, 388 μM, 465 μM, 558 μM, 670 μM, 804 μM, 965 μM, 1157 μM, 1389 μM, 1667 μM, 2000 μM.
None of the real treatment concentrations in both experiments deviated more than 10 % from the nominal concentration. Precipitation of the test item was not visible up to the highest concentration. EGDMA (120 μM) was used as positive control. The viability was above 70 % and a distinct increase in luciferase induction above 2.5 fold in comparison to the solvent control was detected. This luciferase induction is well within the historical data range of the positive control.D/L-lactic acid (5000 μM) was used as negative control. The viability was above 70 % and the induction of the luciferase was < 1.5 fold in comparison to the solvent control and well within the historical data range of the negative control. The induction of the luciferase of the growth control was < 1.5 fold. Since all acceptability criteria of the assay were met the study is valid. No significant reduction of growth was observed in all tested test item concentrations. Therefore, all tested concentrations could be evaluated for luciferase induction. In all tested concentrations of the test item no substantial and reproducible dose dependent increase of luciferase induction was measured.
In conclusion, it can be stated that under the experimental conditions reported, the test did not have the potential to activate the Nrf2 transcription factor.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.